| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 47 | 2023 | 165 | 7.850 |
Why?
|
| Urodynamics | 69 | 2021 | 347 | 7.180 |
Why?
|
| Urinary Bladder | 63 | 2023 | 1172 | 4.950 |
Why?
|
| Urinary Incontinence | 36 | 2021 | 496 | 3.600 |
Why?
|
| Intermittent Urethral Catheterization | 4 | 2023 | 13 | 3.220 |
Why?
|
| Urination Disorders | 22 | 2018 | 241 | 2.840 |
Why?
|
| Urinary Tract | 21 | 2023 | 309 | 2.640 |
Why?
|
| Meningomyelocele | 22 | 2012 | 165 | 2.450 |
Why?
|
| Urethra | 32 | 2020 | 408 | 2.250 |
Why?
|
| Vesico-Ureteral Reflux | 39 | 2022 | 427 | 2.040 |
Why?
|
| Urinary Bladder Diseases | 17 | 2016 | 166 | 1.620 |
Why?
|
| Urologic Diseases | 7 | 2016 | 244 | 1.560 |
Why?
|
| Neural Tube Defects | 12 | 2017 | 256 | 1.540 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2021 | 213 | 1.350 |
Why?
|
| Spinal Dysraphism | 6 | 2017 | 161 | 1.290 |
Why?
|
| Urogenital Abnormalities | 9 | 2022 | 261 | 1.280 |
Why?
|
| Urology | 6 | 2015 | 399 | 1.220 |
Why?
|
| Nocturnal Enuresis | 4 | 2019 | 12 | 1.100 |
Why?
|
| Urinary Bladder, Overactive | 5 | 2021 | 106 | 1.090 |
Why?
|
| Diagnostic Techniques, Urological | 4 | 2015 | 28 | 1.080 |
Why?
|
| Fecal Incontinence | 5 | 2015 | 239 | 1.050 |
Why?
|
| Child | 173 | 2023 | 77709 | 0.940 |
Why?
|
| Ureter | 15 | 2016 | 375 | 0.910 |
Why?
|
| Neuromuscular Agents | 2 | 2021 | 134 | 0.910 |
Why?
|
| Urinary Tract Infections | 15 | 2023 | 788 | 0.900 |
Why?
|
| Urinary Catheterization | 12 | 2023 | 202 | 0.730 |
Why?
|
| Urination | 13 | 2022 | 204 | 0.710 |
Why?
|
| Losartan | 1 | 2021 | 299 | 0.660 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 451 | 0.610 |
Why?
|
| Defecation | 3 | 2017 | 188 | 0.590 |
Why?
|
| Constipation | 5 | 2015 | 546 | 0.570 |
Why?
|
| Child, Preschool | 109 | 2020 | 41006 | 0.570 |
Why?
|
| Terminology as Topic | 5 | 2015 | 1547 | 0.510 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 604 | 0.500 |
Why?
|
| Spinal Cord | 11 | 2017 | 1809 | 0.480 |
Why?
|
| Fibrosis | 1 | 2021 | 2029 | 0.470 |
Why?
|
| Cerebral Palsy | 3 | 2017 | 459 | 0.460 |
Why?
|
| Varicocele | 6 | 2015 | 78 | 0.450 |
Why?
|
| Urethral Diseases | 4 | 2018 | 53 | 0.440 |
Why?
|
| Infant | 85 | 2020 | 35136 | 0.440 |
Why?
|
| Neurogenic Bowel | 1 | 2012 | 1 | 0.430 |
Why?
|
| Ureteral Obstruction | 11 | 2011 | 296 | 0.430 |
Why?
|
| Urologic Surgical Procedures | 5 | 2016 | 302 | 0.420 |
Why?
|
| Glycopeptides | 1 | 2013 | 224 | 0.410 |
Why?
|
| Digestive System Abnormalities | 1 | 2012 | 52 | 0.410 |
Why?
|
| Syringomyelia | 1 | 2012 | 64 | 0.410 |
Why?
|
| Humans | 229 | 2023 | 744343 | 0.400 |
Why?
|
| Biofeedback, Psychology | 2 | 2009 | 115 | 0.390 |
Why?
|
| Writing | 1 | 2013 | 206 | 0.390 |
Why?
|
| Urography | 11 | 2016 | 313 | 0.390 |
Why?
|
| Kidney | 23 | 2022 | 7186 | 0.390 |
Why?
|
| Antidiuretic Agents | 2 | 2012 | 24 | 0.380 |
Why?
|
| Adolescent | 92 | 2022 | 85781 | 0.380 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 2012 | 91 | 0.370 |
Why?
|
| Intestines | 5 | 2017 | 1924 | 0.370 |
Why?
|
| Mandelic Acids | 4 | 1999 | 47 | 0.370 |
Why?
|
| Urinary Sphincter, Artificial | 2 | 2008 | 24 | 0.360 |
Why?
|
| Quality of Life | 5 | 2017 | 12804 | 0.350 |
Why?
|
| Diverticulum | 4 | 2009 | 136 | 0.340 |
Why?
|
| Self Concept | 1 | 2015 | 1025 | 0.340 |
Why?
|
| Hydronephrosis | 15 | 2011 | 269 | 0.330 |
Why?
|
| Male | 159 | 2022 | 350118 | 0.330 |
Why?
|
| Pediatrics | 4 | 2015 | 3475 | 0.320 |
Why?
|
| Kidney Pelvis | 4 | 2017 | 188 | 0.320 |
Why?
|
| Hypospadias | 8 | 2001 | 92 | 0.320 |
Why?
|
| Infant, Newborn | 52 | 2018 | 25625 | 0.310 |
Why?
|
| Intestine, Small | 1 | 2014 | 1241 | 0.310 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 3396 | 0.300 |
Why?
|
| Cholinergic Antagonists | 4 | 2003 | 165 | 0.300 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1880 | 0.290 |
Why?
|
| Fetus | 3 | 2012 | 1880 | 0.290 |
Why?
|
| Pressure | 6 | 2018 | 1203 | 0.290 |
Why?
|
| Urethral Stricture | 3 | 2017 | 51 | 0.290 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1405 | 0.280 |
Why?
|
| Patient Compliance | 4 | 2015 | 2684 | 0.280 |
Why?
|
| Toilet Training | 2 | 2019 | 18 | 0.280 |
Why?
|
| Fetal Diseases | 2 | 2011 | 903 | 0.270 |
Why?
|
| Enuresis | 4 | 2006 | 47 | 0.270 |
Why?
|
| Female | 128 | 2022 | 380194 | 0.260 |
Why?
|
| Testis | 7 | 2015 | 803 | 0.260 |
Why?
|
| Consensus | 6 | 2017 | 2959 | 0.260 |
Why?
|
| Bladder Exstrophy | 4 | 2014 | 107 | 0.250 |
Why?
|
| Bulbourethral Glands | 1 | 2004 | 7 | 0.250 |
Why?
|
| Spina Bifida Occulta | 4 | 2000 | 31 | 0.250 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2278 | 0.250 |
Why?
|
| Sacrum | 5 | 2012 | 288 | 0.250 |
Why?
|
| Postoperative Complications | 20 | 2011 | 15295 | 0.240 |
Why?
|
| Urinary Diversion | 10 | 2003 | 138 | 0.240 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2576 | 0.240 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 84 | 0.240 |
Why?
|
| Muscle, Smooth | 5 | 2015 | 934 | 0.230 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1151 | 0.230 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3036 | 0.220 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2266 | 0.220 |
Why?
|
| Polyps | 2 | 2003 | 189 | 0.210 |
Why?
|
| Ureteral Neoplasms | 1 | 2003 | 111 | 0.210 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 1432 | 0.210 |
Why?
|
| Meningocele | 3 | 2016 | 45 | 0.210 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 895 | 0.210 |
Why?
|
| Pedigree | 8 | 2020 | 4644 | 0.210 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 19905 | 0.200 |
Why?
|
| Electromyography | 18 | 2020 | 1379 | 0.190 |
Why?
|
| Caregivers | 2 | 2023 | 2094 | 0.190 |
Why?
|
| Ureterostomy | 1 | 2000 | 17 | 0.190 |
Why?
|
| Cystostomy | 1 | 2000 | 26 | 0.190 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1462 | 0.190 |
Why?
|
| Urologic Surgical Procedures, Male | 3 | 2017 | 75 | 0.190 |
Why?
|
| Urinary Bladder Neck Obstruction | 2 | 2000 | 81 | 0.180 |
Why?
|
| Ketorolac | 1 | 2000 | 79 | 0.180 |
Why?
|
| Spasm | 1 | 2000 | 121 | 0.180 |
Why?
|
| Young Adult | 14 | 2022 | 56430 | 0.180 |
Why?
|
| Retrospective Studies | 35 | 2022 | 77449 | 0.180 |
Why?
|
| Cysts | 2 | 2004 | 678 | 0.170 |
Why?
|
| Video Recording | 3 | 2015 | 949 | 0.170 |
Why?
|
| Solanaceous Alkaloids | 1 | 2018 | 3 | 0.160 |
Why?
|
| Fraser Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Orchiopexy | 1 | 2017 | 20 | 0.160 |
Why?
|
| Sacrococcygeal Region | 2 | 2016 | 52 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 102 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 246 | 0.150 |
Why?
|
| Follow-Up Studies | 31 | 2019 | 39050 | 0.150 |
Why?
|
| Parasympatholytics | 3 | 1994 | 91 | 0.150 |
Why?
|
| Rheology | 1 | 2018 | 345 | 0.150 |
Why?
|
| Urethral Obstruction | 1 | 1997 | 56 | 0.150 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2018 | 177 | 0.150 |
Why?
|
| Genetic Linkage | 3 | 2012 | 2421 | 0.150 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 257 | 0.150 |
Why?
|
| Urinary Reservoirs, Continent | 4 | 1998 | 29 | 0.140 |
Why?
|
| Mutation | 5 | 2020 | 29786 | 0.140 |
Why?
|
| Cystoscopy | 6 | 2011 | 134 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 497 | 0.140 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1613 | 0.140 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 161 | 0.130 |
Why?
|
| Societies, Medical | 4 | 2015 | 3743 | 0.130 |
Why?
|
| Diurnal Enuresis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Kidney Diseases | 7 | 2012 | 2149 | 0.130 |
Why?
|
| Urinary Incontinence, Urge | 3 | 2015 | 46 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2018 | 413 | 0.130 |
Why?
|
| Disease Management | 2 | 2016 | 2459 | 0.130 |
Why?
|
| Age Factors | 7 | 2015 | 18370 | 0.130 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15076 | 0.120 |
Why?
|
| Sports | 1 | 2021 | 688 | 0.120 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
| Stomach | 4 | 2000 | 697 | 0.120 |
Why?
|
| Tretinoin | 1 | 2017 | 517 | 0.120 |
Why?
|
| Self Care | 4 | 2012 | 786 | 0.120 |
Why?
|
| Sperm Motility | 1 | 2015 | 253 | 0.120 |
Why?
|
| Abnormalities, Multiple | 4 | 2016 | 1416 | 0.120 |
Why?
|
| Spinal Cord Injuries | 4 | 2008 | 931 | 0.120 |
Why?
|
| Students | 1 | 2023 | 1654 | 0.110 |
Why?
|
| Semen Analysis | 1 | 2015 | 204 | 0.110 |
Why?
|
| Social Participation | 1 | 2015 | 173 | 0.110 |
Why?
|
| Treatment Outcome | 21 | 2016 | 63114 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2016 | 8324 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 471 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 530 | 0.110 |
Why?
|
| Cryptorchidism | 3 | 1999 | 125 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2015 | 631 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 2015 | 880 | 0.110 |
Why?
|
| Anal Canal | 2 | 2012 | 376 | 0.100 |
Why?
|
| Ureterocele | 3 | 2001 | 28 | 0.100 |
Why?
|
| Urinary Calculi | 3 | 2001 | 91 | 0.100 |
Why?
|
| Time Factors | 16 | 2016 | 40075 | 0.100 |
Why?
|
| Parents | 2 | 2022 | 3407 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 417 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 128 | 0.100 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2000 | 79 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7279 | 0.090 |
Why?
|
| Enema | 1 | 2011 | 141 | 0.090 |
Why?
|
| Pain | 3 | 2020 | 4986 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2282 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 174 | 0.090 |
Why?
|
| Rectum | 2 | 2012 | 904 | 0.090 |
Why?
|
| Administration, Intravesical | 2 | 2004 | 91 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2012 | 302 | 0.090 |
Why?
|
| Infant Care | 1 | 2011 | 183 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2018 | 2564 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25043 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8301 | 0.090 |
Why?
|
| Prognosis | 6 | 2019 | 29063 | 0.090 |
Why?
|
| Adult | 42 | 2021 | 214055 | 0.090 |
Why?
|
| Muscarinic Antagonists | 3 | 2015 | 137 | 0.090 |
Why?
|
| Kidney Calices | 1 | 2009 | 26 | 0.090 |
Why?
|
| Testicular Hydrocele | 1 | 2008 | 28 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3023 | 0.080 |
Why?
|
| Disease Progression | 3 | 2017 | 13284 | 0.080 |
Why?
|
| Rupture, Spontaneous | 2 | 2004 | 354 | 0.080 |
Why?
|
| Neurologic Examination | 5 | 1997 | 930 | 0.080 |
Why?
|
| International Cooperation | 1 | 2015 | 1420 | 0.080 |
Why?
|
| Spermatic Cord Torsion | 2 | 2005 | 73 | 0.080 |
Why?
|
| Rats | 5 | 2021 | 24260 | 0.080 |
Why?
|
| Urachus | 2 | 1998 | 18 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 15519 | 0.080 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8642 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 403 | 0.080 |
Why?
|
| Urolithiasis | 1 | 2009 | 131 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 3617 | 0.080 |
Why?
|
| Nomograms | 1 | 2009 | 228 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.070 |
Why?
|
| Kidney Neoplasms | 2 | 2003 | 4262 | 0.070 |
Why?
|
| Physical Examination | 3 | 2012 | 1237 | 0.070 |
Why?
|
| Sperm Count | 1 | 2007 | 216 | 0.070 |
Why?
|
| Eosinophilia | 1 | 1991 | 541 | 0.070 |
Why?
|
| Risk Factors | 9 | 2021 | 72290 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1919 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.070 |
Why?
|
| Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Choristoma | 2 | 1998 | 213 | 0.070 |
Why?
|
| Remission, Spontaneous | 3 | 2009 | 382 | 0.070 |
Why?
|
| Endoscopy | 3 | 2017 | 1785 | 0.070 |
Why?
|
| Testicular Diseases | 1 | 2005 | 71 | 0.070 |
Why?
|
| Anxiety | 1 | 2020 | 4297 | 0.070 |
Why?
|
| Benchmarking | 1 | 2012 | 1042 | 0.070 |
Why?
|
| Laparoscopy | 3 | 2008 | 2151 | 0.070 |
Why?
|
| Scrotum | 3 | 2005 | 115 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14722 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5078 | 0.060 |
Why?
|
| Ultrasonography | 7 | 2022 | 5985 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2531 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17446 | 0.060 |
Why?
|
| Pyelonephritis | 4 | 1980 | 75 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2003 | 57 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2008 | 1206 | 0.060 |
Why?
|
| Heterozygote | 2 | 2020 | 2804 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 1991 | 1387 | 0.060 |
Why?
|
| Observer Variation | 1 | 2009 | 2593 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3610 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 10 | 0.060 |
Why?
|
| Microsurgery | 1 | 2008 | 796 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2011 | 2245 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9648 | 0.060 |
Why?
|
| Teratoma | 1 | 2006 | 395 | 0.050 |
Why?
|
| Radiography | 13 | 1997 | 7023 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 67 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2008 | 2110 | 0.050 |
Why?
|
| Motor Neurons | 5 | 1995 | 844 | 0.050 |
Why?
|
| Lipoma | 2 | 1997 | 334 | 0.050 |
Why?
|
| Spinal Cord Diseases | 2 | 1988 | 298 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1997 | 281 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5853 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.050 |
Why?
|
| Circumcision, Male | 2 | 2017 | 150 | 0.050 |
Why?
|
| Sex Factors | 4 | 2012 | 10397 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1956 | 0.050 |
Why?
|
| Replantation | 3 | 1980 | 148 | 0.050 |
Why?
|
| Reference Standards | 2 | 2015 | 1025 | 0.050 |
Why?
|
| Rhabdomyosarcoma | 2 | 1996 | 382 | 0.050 |
Why?
|
| Radiopharmaceuticals | 3 | 2000 | 2645 | 0.050 |
Why?
|
| Lithotripsy | 1 | 2001 | 143 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 625 | 0.050 |
Why?
|
| Animals | 10 | 2021 | 168757 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12208 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 20947 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6365 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7181 | 0.050 |
Why?
|
| Home Nursing | 2 | 1998 | 92 | 0.040 |
Why?
|
| Epispadias | 1 | 1999 | 18 | 0.040 |
Why?
|
| Reoperation | 6 | 2009 | 4201 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3752 | 0.040 |
Why?
|
| Arabs | 1 | 2021 | 178 | 0.040 |
Why?
|
| Umbilical Arteries | 2 | 1978 | 75 | 0.040 |
Why?
|
| Digestive System | 1 | 2000 | 253 | 0.040 |
Why?
|
| Phenotype | 4 | 2020 | 16365 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 605 | 0.040 |
Why?
|
| Disorders of Sex Development | 1 | 1999 | 122 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 519 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23403 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
| Genetic Counseling | 2 | 1979 | 600 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 804 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 15540 | 0.040 |
Why?
|
| Hospitals, Pediatric | 4 | 2017 | 1775 | 0.040 |
Why?
|
| Electrophysiology | 4 | 1997 | 1308 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3493 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 86 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 1791 | 0.040 |
Why?
|
| DNA | 2 | 2003 | 7301 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 102 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 35421 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2020 | 53288 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1978 | 180 | 0.040 |
Why?
|
| Exons | 2 | 2018 | 2437 | 0.040 |
Why?
|
| Methods | 5 | 1990 | 1129 | 0.030 |
Why?
|
| Nervous System | 1 | 2000 | 554 | 0.030 |
Why?
|
| Kyphosis | 1 | 1998 | 237 | 0.030 |
Why?
|
| Reflex, Abnormal | 2 | 1994 | 84 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2003 | 1092 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4420 | 0.030 |
Why?
|
| Vaginal Neoplasms | 1 | 1996 | 106 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 4740 | 0.030 |
Why?
|
| Ureteral Diseases | 2 | 1989 | 61 | 0.030 |
Why?
|
| Ileum | 3 | 1989 | 565 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 454 | 0.030 |
Why?
|
| Cystitis | 3 | 1994 | 93 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2018 | 23338 | 0.030 |
Why?
|
| Lumbosacral Plexus | 1 | 1995 | 53 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2015 | 174 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 81183 | 0.030 |
Why?
|
| Perineum | 1 | 1996 | 211 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 300 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1994 | 42 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 1695 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1202 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 78 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 20129 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 393 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 191 | 0.030 |
Why?
|
| Nephrology | 1 | 2017 | 263 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2007 | 569 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 849 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 2839 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3768 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14557 | 0.030 |
Why?
|
| Athletes | 1 | 2021 | 1093 | 0.030 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 183 | 0.030 |
Why?
|
| China | 1 | 2019 | 2248 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Boston | 4 | 2017 | 9313 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15226 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 905 | 0.030 |
Why?
|
| Behavior Therapy | 2 | 2013 | 865 | 0.030 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 12959 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1996 | 1622 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 977 | 0.030 |
Why?
|
| Laxatives | 1 | 2013 | 87 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2726 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 1236 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3508 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 85 | 0.030 |
Why?
|
| Cicatrix | 2 | 2012 | 764 | 0.030 |
Why?
|
| Clinical Alarms | 1 | 2012 | 51 | 0.020 |
Why?
|
| Ostomy | 1 | 2011 | 27 | 0.020 |
Why?
|
| Surgical Stomas | 1 | 2011 | 43 | 0.020 |
Why?
|
| Age Distribution | 1 | 1997 | 2902 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.020 |
Why?
|
| Sleep Apnea, Central | 1 | 2012 | 84 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1992 | 215 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13408 | 0.020 |
Why?
|
| Recurrence | 4 | 2011 | 8340 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 458 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4554 | 0.020 |
Why?
|
| Genital Neoplasms, Male | 1 | 1990 | 74 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2012 | 194 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6933 | 0.020 |
Why?
|
| Prolapse | 1 | 1990 | 68 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 282 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12261 | 0.020 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 1107 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1975 | 582 | 0.020 |
Why?
|
| Catheterization | 1 | 1975 | 1470 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2012 | 329 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1989 | 1681 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3147 | 0.020 |
Why?
|
| Base Sequence | 2 | 2015 | 12797 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2015 | 40561 | 0.020 |
Why?
|
| Contrast Media | 1 | 2022 | 5300 | 0.020 |
Why?
|
| Dilatation, Pathologic | 4 | 1989 | 520 | 0.020 |
Why?
|
| Lod Score | 1 | 2009 | 614 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 625 | 0.020 |
Why?
|
| Risk | 4 | 1984 | 9687 | 0.020 |
Why?
|
| Netherlands | 1 | 2013 | 2170 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9386 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 783 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.020 |
Why?
|
| Reflex | 1 | 1989 | 365 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18111 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5456 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2925 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7880 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 498 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 854 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21746 | 0.020 |
Why?
|
| Pregnancy | 3 | 2003 | 29144 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1907 | 0.020 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 2031 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 722 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12026 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1994 | 1640 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13815 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 3002 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1182 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 725 | 0.020 |
Why?
|
| Walking | 1 | 1992 | 1180 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2006 | 1842 | 0.020 |
Why?
|
| Thymine | 1 | 2004 | 68 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2007 | 409 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4803 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2006 | 488 | 0.010 |
Why?
|
| Congenital Abnormalities | 2 | 1998 | 707 | 0.010 |
Why?
|
| Jejunum | 1 | 1985 | 480 | 0.010 |
Why?
|
| Sertoli Cell Tumor | 1 | 1983 | 40 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1983 | 68 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cytosine | 1 | 2004 | 216 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 697 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1983 | 213 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1983 | 98 | 0.010 |
Why?
|
| Technetium | 1 | 1983 | 334 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 458 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 251 | 0.010 |
Why?
|
| Algorithms | 2 | 2015 | 13881 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1983 | 146 | 0.010 |
Why?
|
| Urothelium | 1 | 2004 | 277 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 572 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 170 | 0.010 |
Why?
|
| Retreatment | 1 | 2003 | 610 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1999 | 1486 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2886 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 991 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1986 | 1240 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5952 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 12072 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 599 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5442 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 708 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2003 | 620 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 697 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 1185 | 0.010 |
Why?
|
| Preoperative Care | 2 | 1999 | 2250 | 0.010 |
Why?
|
| Diagnostic Errors | 2 | 1998 | 1257 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 2000 | 225 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 5391 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2012 | 2788 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 286 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1981 | 373 | 0.010 |
Why?
|
| Meckel Diverticulum | 1 | 1978 | 34 | 0.010 |
Why?
|
| Radioisotope Renography | 1 | 1998 | 62 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1701 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1285 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1999 | 1162 | 0.010 |
Why?
|
| Groin | 1 | 1998 | 104 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2618 | 0.010 |
Why?
|
| Ligaments | 1 | 1998 | 128 | 0.010 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1998 | 133 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3701 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1983 | 804 | 0.010 |
Why?
|
| Hernia, Umbilical | 1 | 1978 | 96 | 0.010 |
Why?
|
| Bacteriuria | 2 | 1989 | 102 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1998 | 2186 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1987 | 2972 | 0.010 |
Why?
|
| Surgery, Plastic | 1 | 1983 | 624 | 0.010 |
Why?
|
| Epilepsy | 1 | 2012 | 3310 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 9959 | 0.010 |
Why?
|
| Motor Neuron Disease | 1 | 1996 | 99 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1676 | 0.010 |
Why?
|
| Estradiol | 1 | 1983 | 2020 | 0.010 |
Why?
|
| Hypertension | 1 | 1975 | 8480 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6171 | 0.010 |
Why?
|
| Urinary Retention | 1 | 1995 | 111 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 7939 | 0.010 |
Why?
|
| Appendix | 1 | 1995 | 110 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2503 | 0.010 |
Why?
|
| Vas Deferens | 1 | 1994 | 55 | 0.010 |
Why?
|
| Renal Artery Obstruction | 1 | 1975 | 248 | 0.010 |
Why?
|
| Abscess | 1 | 1978 | 607 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2012 | 12720 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 4217 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6756 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 11124 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1980 | 1312 | 0.010 |
Why?
|
| Penis | 1 | 1994 | 216 | 0.010 |
Why?
|
| Nonlinear Dynamics | 1 | 1996 | 502 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 1107 | 0.010 |
Why?
|
| Testosterone | 1 | 1983 | 2420 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2005 | 3528 | 0.010 |
Why?
|
| Counseling | 1 | 1980 | 1523 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3798 | 0.010 |
Why?
|
| Colon | 1 | 2000 | 1772 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Cell Division | 1 | 1999 | 4568 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1994 | 210 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7799 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1990 | 378 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 318 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 1996 | 804 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 4982 | 0.010 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1990 | 228 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 4776 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12951 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1577 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1994 | 1074 | 0.010 |
Why?
|
| Vincristine | 1 | 1990 | 1039 | 0.010 |
Why?
|
| Orchiectomy | 1 | 1990 | 474 | 0.010 |
Why?
|
| Cecum | 1 | 1989 | 237 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19229 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 2 | 1994 | 1876 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 13989 | 0.000 |
Why?
|
| Neural Inhibition | 1 | 1989 | 602 | 0.000 |
Why?
|
| Artifacts | 1 | 1994 | 1904 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2585 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4669 | 0.000 |
Why?
|
| Cyclophosphamide | 1 | 1990 | 2242 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1990 | 1261 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1999 | 13033 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1990 | 2234 | 0.000 |
Why?
|
| Graft Survival | 1 | 1994 | 3737 | 0.000 |
Why?
|
| Sertoli Cells | 1 | 1983 | 49 | 0.000 |
Why?
|
| Desmosomes | 1 | 1983 | 73 | 0.000 |
Why?
|
| Gram-Positive Bacteria | 1 | 1984 | 184 | 0.000 |
Why?
|
| Oligospermia | 1 | 1983 | 59 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 10252 | 0.000 |
Why?
|
| Vulva | 1 | 1983 | 87 | 0.000 |
Why?
|
| Diuresis | 1 | 1983 | 116 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 4933 | 0.000 |
Why?
|
| Muscles | 1 | 1987 | 1614 | 0.000 |
Why?
|
| Basement Membrane | 1 | 1983 | 356 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1983 | 719 | 0.000 |
Why?
|
| Thrombosis | 1 | 1975 | 2968 | 0.000 |
Why?
|
| Epididymitis | 1 | 1981 | 37 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2645 | 0.000 |
Why?
|
| Vagina | 1 | 1983 | 825 | 0.000 |
Why?
|
| Syndrome | 1 | 1984 | 3251 | 0.000 |
Why?
|
| Myelitis, Transverse | 1 | 1977 | 39 | 0.000 |
Why?
|
| Renal Artery | 1 | 1978 | 398 | 0.000 |
Why?
|
| Tuberous Sclerosis | 1 | 1983 | 1029 | 0.000 |
Why?
|
| Angiography | 1 | 1978 | 1639 | 0.000 |
Why?
|
| Drainage | 1 | 1978 | 1142 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1984 | 4217 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 11524 | 0.000 |
Why?
|
| Middle Aged | 2 | 1995 | 213383 | 0.000 |
Why?
|
| Decision Making | 1 | 1981 | 3887 | 0.000 |
Why?
|